Somatic cells can be reprogrammed into pluripotent stem cells (PSCs) by using pure chemicals, providing a different paradigm to study somatic reprogramming. However, the cell fate dynamics and molecular events that occur during the chemical reprogramming process remain unclear. We now show that the chemical reprogramming process requires the early formation of extra-embryonic endoderm (XEN)-like cells and a late transition from XEN-like cells to chemically-induced (Ci)PSCs, a unique route that fundamentally differs from the pathway of transcription factor-induced reprogramming. Moreover, precise manipulation of the cell fate transition in a step-wise manner through the XEN-like state allows us to identify small-molecule boosters and establish a robust chemical reprogramming system with a yield up to 1,000-fold greater than that of the previously reported protocol. These findings demonstrate that chemical reprogramming is a promising approach to manipulate cell fates.
In Brief
In the process of chemical reprogramming from somatic cells to pluripotent stem cells, an intermediate extraembryonic endoderm (XEN)-like state is uncovered, allowing the development of a robust chemical reprogramming system by manipulating small molecules more precisely through this unique route.
INTRODUCTION
Pluripotent stem cells can be induced from somatic cells by nuclear transfer into oocytes, transgene delivery, or treatment with chemical compounds (Gurdon, 1962; Hou et al., 2013; Takahashi and Yamanaka, 2006) . Chemically induced reprogramming was first demonstrated by our group in 2013, when we showed that pluripotent stem cells can be generated from mouse somatic cells using a cocktail of seven small molecules (Hou et al., 2013) . Chemical reprogramming provides a fundamentally new paradigm for studying pluripotency and cell fate reprogramming (Chou and Cheng, 2013; Hou et al., 2013) . In addition, this chemical strategy shows promise in cell fate manipulation because small molecules can be cell permeable and easy to manipulate, they do not integrate in to chromosomes, and their effect is reversible. Therefore, chemically induced pluripotent stem cells may have many advantages in cell therapy, disease modeling, and drug discovery (Hou et al., 2013; Li et al., 2013) .
To date, the molecule roadmap of the reprogramming process has been extensively studied in experiments that induce pluripotency using the transcription factors Oct4, Sox2, Klf4, and c-Myc (OSKM). As previously reported, the changes in gene expression and epigenetic states are primarily induced by two major waves during reprogramming (Hansson et al., 2012; Polo et al., 2012) . The mesenchymal-to-epithelium transition (MET) mediates an early stage of reprogramming that is induced by OSKM (Li et al., 2010; Samavarchi-Tehrani et al., 2010) , whereas Sox2 initiates a deterministic, later stage of reprogramming (Buganim et al., 2012) . Moreover, a primitive streak-like state has been reported as an intermediate state during the cell fate transition from somatic cells to pluripotent cells (Takahashi et al., 2014) .
Because chemical reprogramming has been established more recently, comparatively little is known about the reprogramming process that is induced by small molecules. In particular, the small-molecule cocktails that are used in chemical reprogramming have been identified by phenotypic screening and do not involve the direct activation of classical reprogramming factors (Hou et al., 2013) , such as Oct4, Sox2, Klf4, and c-Myc. Therefore, it is intriguing to speculate about the similarities and differences between OSKM-induced and chemically induced reprogramming. In addition, a major advantage of the chemical approach is that small molecules can be finetuned in terms of their concentrations, durations, structures, and combinations, providing the opportunity to manipulate the chemically induced pluripotent stem cells (CiPSC) generation process more precisely during each stage of reprogramming. Therefore, the identification of key molecular events and intermediate cell states would help greatly improve the efficiency of reprogramming by allowing for the fine-tuning of small molecules and culture conditions based on the markers of each stage of reprogramming.
In this study, we identified an extraembryonic endoderm (XEN)-like state as an intermediate during the early stage of chemical reprogramming. Moreover, the chemical reprogramming efficiency is greatly enhanced by small-molecule boosters and the more precise optimization of the reprogramming conditions for each step identified with the XEN-like state as an indicator.
RESULT
The Induction of Cell Colonies Expressing XEN Cell Markers Is a Cornerstone Event during Chemical Reprogramming In our previously developed method for inducing pluripotent stem cells from fibroblasts, there are three essential stages in the chemical reprogramming process. During these stages, (B) Numbers of CiPSC colonies generated from the inside (blue) and outside (red) of epithelial colonies in eight batches of experiments. For experiments 5 and 7, the cell confluence of epithelial colonies was <20%. (C) Immunofluorescence of typical epithelial colonies at the end of stage 1, with the expression of SALL4 (top, red) and GATA4 (top, green), SALL4 (bottom, red) and SOX17 (bottom, green) 4 days after replating at day 12. Scale bar, 100 mm. (D) qRT-PCR analysis of XEN cell markers (Gata4, Gata6, Sox17, Sox7, Sall4) and pluripotency marker Oct4 in MEFs, cells at the end of stage 1 (day 16) and stage 2 (day28) and eXEN (embryoderived XEN cells). (E) CiPSC colony numbers generated at the end of stage 3 from EpCAM-negative (À), EpCAM-positive (+) and total cell populations sorted at day 20 (in stage 2 of chemical reprogramming). Data are represented as mean ± SD. See also Figure S1 . a cocktail of five small molecules, ''VC6TF'' (VPA, CHIR99021, 616452, tranylcypromine, and forskolin), was used in stage 1 for 16-20 days; another small molecule, DZNep, was added at the start of stage 2 for the next 20-24 days; and 2i-medium (with dual inhibition of ERK and GSK3 with PD0325901 and CHIR99021, respectively) was used in stage 3 for the last 12-16 days. In total, the chemical reprogramming process can take as long as 48-60 days (Hou et al., 2013) .
To dissect the chemical reprogramming process, we carefully followed the change in cell morphology during chemical reprogramming in each stage. Notably, we found that at the end of stage 1, a number of epithelial colonies formed, and these epithelial cells rapidly expanded during stage 2. More importantly, by tracing the dynamic changes in cell fate during chemical reprogramming, we found that CiPSCs predominantly emerged from the inside of these epithelial cell colonies ( Figures  1A, 1B , and S1A). In some experiments, 100% of the CiPSCs were generated from these colonies, even when the cells were re-plated at a lower density; the epithelial cell colonies had grown to <20% confluence. These findings indicate that CiPSCs may be generated from these epithelial cells.
To better understand these epithelial colonies as the potential intermediates of chemical reprogramming, we next used immunofluorescence and qRT-PCR to examine the gene expression pattern of these epithelial cell colonies. By immunofluorescence, we found that all epithelial colonies formed in the end of stage 1 co-expressed SALL4, GATA4, and SOX17, master genes of XENs (Lim et al., 2008) (Figure 1C ). Our qRT-PCR analysis further detected the expression of other XEN marker genes, such as Sox7 and Gata6 in these colonies ( Figure 1D ). More importantly, we found expression level of these genes was comparable to that of embryo-derived XEN cells (eXENs) (Kunath et al., 2005) ( Figure 1D ). Then, we referred to the epithelial cells expressing XEN markers as XEN-like cells.
We next examined whether these XEN-like cells represent an intermediate state of chemical reprogramming. Using a XENexpressing surface protein, EpCAM, we enriched XEN-like cells by fluorescence-activated cell sorting (FACS) and found that selection for EpCAM-positive cells greatly enriched the proportions of cells forming XEN-like cell colonies and subsequently generating CiPSCs by >20-fold ( Figures 1E and S1B) . Moreover, in another study by our group, we generated CiPSCs from neural stem cells and intestinal epithelial cells (Ye et al., 2015) and found that EpCAM also strongly enriched the cells that formed XEN-like colonies during chemical reprogramming and further generated CiPSCs from these two initial cell types ( Figure S1C ).
In addition, we speculated that transitional colonies that co-expressed XEN master genes and pluripotency-associated genes could be captured, if pluripotent stem cells were induced from XENlike cells. To determine this, we detected cells that co-expressed GATA4 and OCT4 during stage 2 of reprogramming ( Figure S1D ), and we observed cell colonies in stage 3 expressing GATA4 in the peripheral and expressing pOct4-GFP in the middle of the colonies, which could be the cell colonies under cell fate transition from XENlike cells to pluripotent stem cells ( Figure S1D) 
Identification of Small Molecules that Promote the Transition from Fibroblasts to XEN-like Cells
The identification of an intermediate state of chemical reprogramming provides a new opportunity to optimize the reprogramming conditions and to screen novel small-molecule boosters in early reprogramming by using XEN-like colony numbers as the readout. In our previous study, we found that an enhanced concentration of CHIR99021 (from 10 mM to 20 mM) during stage 1 facilitates the generation of CiPSCs from neonatal and adult fibroblasts (Hou et al., 2013) . Here, we found that the increased concentration of CHIR99021 is also beneficial for the formation of XEN-like colonies from MEFs ( Figure 2A ). Through qRT-PCR analysis, we found that this increased concentration of CHIR99021 promotes an up to 10-fold increase in the expression of XEN master genes Gata4 and Sox17 and an epithelium cell marker, EpCAM ( Figures 2B  and S2A ).
Next, we tested the effects of a selected small-molecule library of previously reported reprogramming boosters (Mikkelsen et al., 2008; Onder et al., 2012; Wang et al., 2011) in the presence of a small-molecule cocktail, VC6TF, with 20 mM CHIR99021, on the reprogramming of cell fate from fibroblasts to XEN-like cells. Among the tested small molecules, an RA agonist, AM580 (A), and a DOT1L inhibitor, EPZ004777 (E), enhanced the formation of XEN-like colonies by 2-to 3-fold ( Figure 2C ). When these small molecules were used together in a cocktail of seven small molecules, VC6TFAE, the number of XEN-like colonies was enhanced by >5-fold ( Figure 2C ). These findings were further validated by counting the numbers of SALL4 and GATA4 double-positive colonies and by detecting the expression of XEN marker genes by qRT-PCR ( Figures 2D, 2E , and S2B-S2D). Together, the numbers of XEN-like colonies, an indicator of early reprogramming, could be enhanced more than 50-fold by adjusting the small molecule concentrations and adding additional small molecules. 
The Identification of Small Molecules that Promote the Transition from a XEN-like to a Pluripotent State
The enhanced generation of XEN-like colonies facilitated the screening of small molecules that promote the transition from XEN-like cells to CiPSCs during stages 2 and 3. Previously, the optimized duration for stage 2 was 20-24 days; few CiPSC colonies could be obtained if stage 2 was shortened to 12 days (Hou et al., 2013) . Here, we conducted small-molecule screenings in the presence of small molecule cocktail VC6TFA plus DZNep (Z) for only 12 days instead of 20-24 days of stage 2. After screening 88 selected small molecules, we found that CiPSC colonies formed in stage 3 only when supplemented with 5-aza-dC during stage 2 ( Figure 3A ). Next, we found that 5-aza-dC (D) and EPZ004777 (E) had synergistic effects and promoted the kinetics of stage 2 ( Figure 3A ). By using a cocktail of eight small molecules, VC6TFAZDE, for 12 days during stage 2, we were able to obtain up to 20 CiPSC colonies from 100,000 re-plated cells at the end of the reprogramming process of 44 days ( Figure 3A ). In contrast, few CiPSC colonies were obtained during the same time course without 5-aza-dC and EPZ004777.
Strikingly, when we used another DOT1L inhibitor, SGC0946 (S), in place of EPZ004777 during stage 2 (Figures S3A and S3B), the reprogramming efficiency was increased further by as much as 5-fold ( Figures 3A and 3B ), particularly when an optimized 2i-medium (N2B27-2iL medium) was used (Figures 3C and S3B) . Next, we further optimized the duration and concentration of the small molecules and the re-plating cell density (Figures 3D, 3E, . Using the small-molecule cocktail VC6TFAZDS during stage 2 for 12 days, we were able to induce $100-600 CiPSC colonies from 50,000 re-plated cells during the final stage of chemical reprogramming. Notably, although SGC0946 can be more effective than EPZ004777 during stage 2, SGC0946 was not able to substitute for EPZ004777 during stage 1 because cell viability was decreased if SGC0946 was used from the start of chemical reprogramming. Importantly, CiPSC colonies emerged from 24%-53% of the XENlike colonies in five independent experiments, indicating the transition ratio of a single XEN-like cell in the start of stage 2 to CiPSCs in the end of stage 3 ( Figure S3F ). In addition, almost all CiPSC colonies were derived from XEN-like colonies, even though the efficiency was greatly improved ( Figure S3G ).
In particular, we found that the duration of the small-molecule treatment and the re-plating cell density were both highly critical during the later stages of reprogramming. Although the old protocol favors a re-plating cell density of 300,000 cells per well (Hou et al., 2013) , the new protocol favors a cell density of 50,000-100,000 cells per well of a 6-well plate ( Figure 3D ). Furthermore, our initial protocol required 20-24 days of reprogramming during stage 2 to achieve optimal reprogramming efficiency (Hou et al., 2013) , whereas our new protocol had an optimal stage 2 duration of 12 days ( Figure 3E ). In summary, we were able to greatly improve the cell transition from XEN to pluripotent stem cells by adding new small molecules, modifying the small-molecule structure and optimizing the re-plating density and time course of small-molecule treatment.
A Robust CiPSC Induction Protocol Was Established by
Modulating the Cell Transitions through a XEN-like State Next, we combined the optimized reprogramming conditions for stages 1, 2, and 3. Using this new protocol, a well of 50,000 initial fibroblasts was induced, and the cells were expanded to >1,000,000 or more re-plated cells (re-plated into 10-15 wells). A total of 1,000-9,000 CiPSC colonies were obtained at the end of the reprogramming period with a total induction time of 40 days (16, 12, and 12 days for stages 1, 2, and 3, respectively) ( Figure 4A ). Moreover, this new protocol was reproduced independently more than 30 times, and CiPSCs could also be generated from neonatal dermal fibroblasts (MNFs) and adult lung fibroblasts (MAFs) at a significantly enhanced efficiency ( Figure 4B ).
We further examined the minimal time course required in inducing CiPSCs by using this new small-molecule cocktail and the optimized reprogramming conditions. We found that a minimum of 12 days were required in the formation of XEN-like colonies (cells were re-plated at day 8), and at least another 14 days were required to induce CiPSCs from XEN-like cells (Figure 4C ). In total, at the cost of efficiency, a minimum of 26 days are required to induce CiPSCs by using the new protocol (Figure 4C ). In comparison, at least 44 days were required to generate only 0-1 CiPSC colony from 40,000 initial cells using the original protocol at day 44.
CiPSC colonies were then picked to establish CiPSC lines for further characterization. As shown by qRT-PCR and immunostaining, the CiPSCs expressed all the tested marker genes for pluripotent stem cells, such as Oct4, Sox2, and Nanog ( Figures  4D and 4E ). Using RNA sequencing (RNA-seq), we found that CiPSCs induced with this new protocol had gene expression profiles similar to those of ESCs ( Figures S4A and S4B ). CiPSCs were further tested for their potential for in vivo development, and we found that all six tested CiPSC lines were able to form teratoma after injection into SCID mice ( Figure 4F ) and generate chimeric mice after blastocyst injection ( Figure 4G ). Among five tested CiPSC lines, four lines showed germline integration potential in chimeric mice, and germline transmission offspring were obtained from chimeric mice ( Figure 4G ). Moreover, CiPSCs were maintained with normal karyotypes ( Figure S4C ). Together, these results indicate that we were able to establish a robust CiPSC induction protocol by manipulating the cell fate transition more precisely through the XEN-like state.
Gene Expression Dynamics during CiPSC Generation
The robust CiPSC induction method developed here allowed us to better study the molecular mechanisms underlying the reprogramming process. We then examined the expression of some typical pluripotency-associated genes during chemical reprogramming, and we revealed the sequential expression of pluripotency genes ( Figures 5A and 5C ). Through single cell qRT-PCR, we found that $50% of the cells in stage 2 co-expressed XEN cell markers ( Figure S5A ). (Hou et al., 2013) . In total, 1-20 CiPSC colonies (in 2 wells) were induced from initial 50,000 fibroblasts in a 60-day induction using the initial protocol. Whereas 1,000-9,000 CiPSC colonies (in 10-15 wells) were obtained from initial 50,000 fibroblasts after 40 days of small-molecule treatment by using the new protocol. 2iL represents 2i-medium with LIF. Notably, similar to embryo-derived XEN cells, the XEN-like cells formed during chemical reprogramming expressed several pluripotency genes, such as Sall4 and Lin28a, during the early stages of reprogramming (Lim et al., 2008; McDonald et al., 2014) (Figures 5A-5C ). During an extended time in culture, the XEN-like cells expressed other pluripotency-associated genes on days 16-28, such as Oct4, Esrrb, and Dppa2 ( Figures 5B  and 5C ). During stage 3, the expression of most pluripotency marker genes, including Nanog, was activated in CiPSCs (Figures 5B and 5C ). This finding indicates a process of sequential gene activation from XEN-like cells to pluripotent stem cells. Interestingly, Sall4, Lin28a, Esrrb, the major genes associated with pluripotency that are highly expressed during stages 1 and 2 of cell reprogramming, have previously been reported to be predictive markers of transcription factor-induced reprogramming and to be sufficient for inducing iPSCs with high quality when concomitantly expressed with Nanog (Buganim et al., 2012 (Buganim et al., , 2014 .
Next, we examined the role of additional small molecules. Through qRT-PCR analysis and RNA sequencing, we found that AM580 and EPZ004777 both promote the expression of XEN marker genes, such as Sall4, Gata4, and Sox17, during stage 1 of chemical reprogramming from fibroblasts to XENlike cells ( Figure 2E ). SGC0946 and 5-aza-dC promote the expression of pluripotency genes, such as Oct4 and Dppa family genes in XEN-like cells, during stage 2 of chemical reprogramming ( Figure S5B ). These findings indicate that stage 1 of chemical reprograming into XEN-like cells is promoted by additional small molecules that act by enhancing the expression of XEN master genes, and stage 2 can be shortened possibly due to the enhanced activation of pluripotency-associated genes by additional small molecules.
We next investigated whether the reprogramming process through a XEN-like state is a unique route toward pluripotency compared to that of the transgenic strategy, which uses OSKM (Takahashi et al., 2007 (Takahashi et al., , 2014 Takahashi and Yamanaka, 2006) . Notably, OSKM-induced reprogramming processes do not show XEN gene profiles, analyzed by qRT-PCR ( Figure 5B ). This finding was also consistent with the previous gene profiling data during the reprogramming process in other reports (Golipour et al., 2012; Mikkelsen et al., 2008; Polo et al., 2012; Sridharan et al., 2009) (Figure S5C ).
Moreover, we further examined whether primitive streak genes were expressed during the chemical reprogramming process, because a primitive streak state has been reported during the process of OSKM-induced reprogramming (Takahashi et al., 2014) . The expression of primitive streak markers, such as T and Mixl1, was not detected during chemical reprogramming (Figure 5A) , demonstrating a unique XEN-like state during the chemical reprogramming process, which differs from that of the reprogramming induced by transgenes ( Figure 5D ).
XEN Master Gene Expression Is Essential during Chemical Reprogramming
To further support the XEN state as an intermediate for chemical reprogramming and to understand the role of XEN master genes in chemical reprogramming, we performed knockdown and ectopic expression experiments. We found that the knockdown of any one of the key XEN genes Sall4, Gata4, Gata6, or Sox17 led to a significant downregulation in the mRNA levels of the other XEN genes and decreased XEN-like colony numbers, thus resulting in less Oct4 expression and fewer CiPSCs at the end of the reprogramming period ( Figures 6A-6C , S6A, and S6B). Consistently with our previously results, the expression of XEN genes was essential to Oct4 expression (Hou et al., 2013; Shu et al., 2013 Shu et al., , 2015 . Moreover, in another study, we found that XEN-gene expression was also enhanced in in chemical reprogramming from neural stem cells and intestinal epithelium cells (Ye et al., 2015) , and the knockdown of these genes impaired XEN-like colony formation and further CiPSC induction from these two initial cell types ( Figure S6C ). These results further indicate that the XEN-like state is essential to the chemical reprogramming process. In contrast, these XEN master genes, such as Gata4, Gata6, and Sox17, were not required in OSKM-induced reprogramming ( Figure S6D ), which suggest different roadmaps underlying chemical reprogramming and OSKM-induced reprogramming ( Figure 5D ).
Furthermore, we found that the overexpression of two of the XEN master genes (SALL4 plus GATA4 or SALL4 plus GATA6) in fibroblasts sufficed in inducing XEN-like colony formation in the absence of the three key small molecules, CHIR99021, 616452, and forskolin ( Figure 6D ). The resulting XEN-like cells showed gene expression pattern similar to that of the small molecule-induced XEN-like cells ( Figure S6E ). Moreover, Oct4 expression was detected in the XEN-like colonies induced by the two combinations of XEN cell master transcription factors ( Figures 6E and 6F ). These findings suggest that XEN genes are both necessary and sufficient to initiate the expression of Oct4, a master gene of pluripotency.
Notably, although these XEN master gene-induced XEN-like cells expressed Oct4, they could not be further reprogrammed into iPSCs, even with a prolonged culture in 2i-medium. We Takahashi et al., 2014) , whereas in chemically induced reprogramming, as reported in this study, a unique XEN-like state bridges the transition of fibroblasts to CiPSCs. Data are represented as mean ± SD. See also Figure S5 . 
(legend continued on next page)
found the exogenous XEN genes downregulated the endogenous expression of Sox2 ( Figure S6F ). Accordingly, when Sox2 was exogenously provided in an appropriate time window after XEN gene overexpression, iPSCs were obtained ( Figures 6G  and S6G ). This finding is consistent with our previous findings of a seesaw model in regulating pluripotency establishment, in which the Gata family genes and Sox2 should be in a balance to achieve pluripotency (Shu et al., 2013) , whereas in chemical reprogramming such a balance could be a dynamic process rather than a steady equilibrium ( Figure 6H ).
The XEN-like Intermediates Resemble Embryo-Derived XEN Cells in Gene Expression Patterns, In Vivo Development Potential, and Reprogramming Potential To better understand this XEN-like state, we further compared the chemically-induced XEN-like cells to embryo-derived XEN cells (eXENs) (Kunath et al., 2005) . We found that XEN-like cells could not be maintained in the traditional XEN culture medium ( Figure S7A ), whereas eXEN cell lines could be maintained long-term and expanded in the stage 1 medium of chemical reprogramming for more than 27 passages, with the gene expression pattern and in vivo development potential similar to eXENs maintained in traditional XEN medium ( Figures 7A-7D , S7B, and S7C). In addition, we found that by using stage 1 medium with chemical cocktail VC6TF, chemically-derived eXEN cell lines (CeXENs) could be established directly from blastocysts and expanded long-term for >32 passages, with a XEN-like gene expression pattern and in vivo integration capability into extraembryonic parietal endoderm ( Figures 7A-7D, S7B, and S7C) .
By qRT-PCR, we found XEN-like cells express a comparable level of XEN master genes to that of eXENs and CeXEN ( Figures  1D, 7A , and 7B). Through global gene expression profiling at the end of stages 1 and 2, we found that XEN-like cells showed gene expression profiles close to eXENs and CeXENs ( Figure 7C ). Through a principal component analysis (PCA) analysis of gene expression profiling, we found a clear roadmap from fibroblasts toward pluripotent stem cells through such a XEN-like state close to eXENs and CeXENs ( Figure 7D ).
In particular, the XEN-like intermediates in chemical reprogramming were closer to CeXENs than traditional eXENs in gene expression profiles ( Figures 7C and 7D) . Moreover, we found that mRNA level of EpCAM, Cdh1 and Sox2 in XEN-like cells and CeXENs was notably higher than that in traditional eXENs ( Figures 7A and S7D) . It is possible that these differences between XEN-like cells and traditional eXENs in gene expression pattern were resulted from their different culture conditions. Interestingly, when we further checked gene profiling data of in vivo XENs in a previous report (Yan et al., 2013) , we found that the authentic XEN cells in vivo express EPCAM and CDH1 in a high level comparable to that of ESCs and express SOX2 in a relatively low level, a pattern similar to that of XEN-like cells and CeXENs, but not eXENs ( Figures S7D and S7E ). These suggest that although XEN-like cells showed some differences to eXENs in culture conditions and gene expression patterns, they were more similar to CeXEN, another type of embryoderived XEN cells.
We further examined the in vivo development potential of XENlike cells during chemical reprogramming. XEN-like cells induced in different time courses of chemical reprogramming were injected into mouse blastocysts. Similarly to eXEN cells, XENlike cells at days 11-25 of chemical reprogramming were able to integrate into the parietal endoderm of the extraembryonic tissues with a comparable efficiency of eXENs, without any integration in the embryos (Figures 7A, 7E, and S7C ). In particular, XEN-like cells in day 16 of chemical reprogramming showed the highest ratio of XEN integration ( Figure S7C ). These findings suggest that XEN-like cells resemble embryo-derived XEN cells in terms of development potential.
Furthermore, we found that either eXENs derived by traditional XEN culture medium or CeXENs established by the stage 1 medium of chemical reprogramming, were capable of further reprogramming into CiPSCs by using the protocol of late chemical reprogramming in stages 2 and 3 ( Figures 7A and 7F) . Notably, 17-34 CiPSC colonies were generated from 2,000 CeXENs within 24 days, a reprogramming efficiency even higher than that of XEN-like cells. CiPSCs generated from eXENs and CeXENs were further characterized to possess an expression pattern similar to pluripotency stem cells and the potential to generate chimeric mice ( Figures 7F, S7F , and S7G). These findings further support that XEN-like cells induced in the early stage of CiPSC generation, which were similar to CeXENs, were amenable to being further reprogrammed in the late stage of chemical reprogramming ( Figure 7A ).
DISCUSSION
Our discovery of the XEN-like state uncovered a unique route in chemical reprogramming of somatic cells toward pluripotency, but not in OSKM-induced reprogramming with a reported primitive streak-like intermediates (Takahashi et al., 2014) (Figure 5D ). Similarly to XEN cells in vivo, the induced XEN-like cells have already expressed Sall4 and Lin28a, two master genes of pluripotency. It is possible that the shared genes expressing in both XEN cells and pluripotent stem cells, such as Sall4 and Lin28a, make the pluripotency state more accessible during the cell fate transition from the XEN-like state to pluripotency. Moreover, we demonstrated the sequential expression of many pluripotency marker genes, such as Oct4 and Esrrb, in XEN-like cells, during stage 2 of chemical reprogramming, indicating that the pluripotency network is easily initiated in XEN-like cells. This finding is consistent with the recent report that in vivo XEN cells spontaneously transition into cells constituting epiblast, which are pluripotent (Xenopoulos et al., 2015) . Interestingly, in stage 3 of chemical reprogramming, 2i-medium containing a FGF/ERK signaling inhibitor, PD0325901, initiated the expression of Nanog and Sox2 in XEN-like cells and cell fate conversion (legend continued on next page) into pluripotent cells, reminiscent of the cell fate determination between primitive endoderm (also known as XEN) and epiblast regulated by FGF/ERK signaling in the mouse blastocyst as previously reported (Yamanaka et al., 2010) . The compatibility of gene expression in XEN and pluripotent cells and the close relations of XEN and epiblast in development make the XEN-like state an ideal bridge toward pluripotency.
Moreover, the master genes of XEN activated during chemical reprogramming directly contribute to the establishment of pluripotency. Our group has previously shown that Gata4 and Gata6, two of the XEN-genes, were able to substitute for Oct4 in transgenic reprogramming in the presence of exogenous Sox2, Klf4, and c-Myc (Shu et al., 2013) . In addition, they were found to activate the expression of Sall4 and subsequently Oct4 (Shu et al., 2015) . In this study, we found the overexpression of Sall4 and Gata4/6, master genes of XENs, is sufficient to stimulate the expression of Oct4, independent of the key small molecules that used in chemical reprogramming. Together, XEN-like cells could be a unique intermediate state of somatic reprograming, which is primed for further reprogramming.
However, in the later stage of reprogramming, these XEN genes need to be silenced to stimulate the expression of additional pluripotency genes, such as Nanog and Sox2. As reported, there were several mutual antagonistic mechanisms between XEN genes and pluripotency-associated genes, such as the competition between Sox17 and Sox2 and the incompatibility between Gata6 and Nanog (Aksoy et al., 2013; Chazaud et al., 2006; Niakan et al., 2010) . In this study, we found the expression of Sox2 was repressed by the XEN genes. We also show that the previously reported ''seesaw'' between XEN genes and Sox2 (Shu et al., 2013) is still required at the end of chemical reprogramming, as the exogenously provided Sox2 is required and sufficient to fulfil the late stage reprogramming initiated by the overexpression of Sall4 and Gata4/6. These indicate the seesaw model in chemical reprogramming is more dynamic rather than a steady equilibrium, and the XEN-like state is transient in chemical reprogramming serving as a bridge of cell fate transitions from somatic cells to pluripotent stem cells, which can be ''burned'' when pluripotency is achieved.
Most important, the identification of the unique route mediated by the XEN-like state allows manipulating cell fate transitions more precisely in a stepwise manner. Chemical reprogramming efficiency was greatly improved by adding new small molecules to the cocktails at each stage, adjusting the concentration of CHIR99021, changing the components of the 2i-medium, modifying the small-molecule structure, and optimizing the re-plated cell density and time course of small-molecule treatment. Most notably, by slightly modifying the structure of EPZ004777 to become SGC0946, which is added in stage 2, the efficiency of chemical reprogramming was significantly increased. To date, the total yields of CiPSC colonies have been enhanced by up to 1,000-fold compared to the use of old protocol. Together, these findings show a major advantage for the smallmolecule approach compared to the transgenic approach, as small molecules are easier to combine, control, optimize, adjust, and withdraw, thereby controlling gene expression and cell fate more precisely both spatially and temporally.
Overall, our discovery of the XEN-like state during chemical reprogramming in this study and our previous findings regarding the role of Gata family genes in inducing pluripotency together reveal a unique route toward pluripotency. In addition, small molecule-induced cell fate reprogramming can be greatly enhanced when manipulated more precisely by small molecule fine-tuning. Thus, chemical reprogramming provides a unique, promising strategy for future applications and for better understanding cell pluripotency and cell fate reprogramming.
EXPERIMENTAL PROCEDURES CiPSC Induction from Fibroblasts
Small molecules that used in this study were described in Table S1 . In an optimized protocol, MEFs were plated at 300,000 cells per 100 mm dish, or 50,000 cells per well of a 6-well plate. The next day (day 0), the culture was changed into stage 1 medium (containing 100 ng/ml bFGF, 0.5 mM VPA, 20 mM CHIR99021, 10 mM 616452, 5 mM tranylcypromine, 50 mM forskolin, 0.05 mM AM580 and 5 mM EPZ004777). On day 12, the cells were trypsinized, harvested and then re-plated at 50,000-200,000 cells per well of a 6-well plate (1:10-15). During days 12-16, concentrations of bFGF, CHIR, and forskolin were reduced to 25 ng/ml, 10 mM, and 10 mM, respectively. On day 16, XEN-like epithelial colonies were formed and the culture was changed into stage 2 medium (containing 25 ng/ml bFGF, 0.5 mM VPA, 10 mM CHIR99021, 10 mM 616452, 5 mM tranylcypromine, 10 mM forskolin, 0.05 mM AM580, 0.05 mM DZNep, 0.5 mM 5-aza-dC, and 5 mM SGC0946). On day 28, the culture was transferred into stage 3 medium (N2B27-2iL medium with 3 mM CHIR99021, 1 mM PD0325901, and 1,000 U/ml LIF). After another 8-12 days, 2i-competent, ESC-like, and GFP-positive (if using pOct4-GFP reporter) CiPSC colonies emerged and were then picked up for expansion and characterization.
XEN-like Cells Chimera Assay GFP-labeled XEN-like cells were induced from the GFP-labeled MEFs. For chimera test, GFP-labeled XEN-like cell colonies were picked and trypsinized to single cells. Approximately 10-15 XEN-like cells were injected into blastocysts and transferred to the uterus of E2.5 pseudopregnant females. Chimera conceptus between E6.5-8.5 were dissected carefully to keep the parietal yolk sac intact and observed with fluorescence stereoscopy.
CiPSC Induction from eXEN Cells eXENs (or CeXENs) were plated at 4,000-20,000 cells per well of a 6-well plate on MEF feeders. Following the treatment with stage 1 medium for 4 days (optional), stage 2 medium for 12 days, and stage 3 medium for another 8-12 days, 2i-competent, ESC-like CiPSC colonies emerged and were then picked up for expansion and characterization.
A more detailed description of the materials and methods is provided in the Supplemental Experimental Procedures. All animal procedures were performed according to the Animal Protection Guidelines of Peking University, China. 
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